Share this content in WeChat
Clinlcal Guidelines & Expert Consensu
Interpretation of expert consensus on non-invasive imaging in coronary syndromes
CHEN Xingrui  ZHAO Shihua 

Cite this article as: CHEN X R, ZHAO S H. Interpretation of expert consensus on non-invasive imaging in coronary syndromes[J]. Chin J Magn Reson Imaging, 2023, 14(10): 1-6. DOI:10.12015/issn.1674-8034.2023.10.001.

[Abstract] Coronary syndrome is one of the cardiovascular diseases with high morbidity and mortality, and early detection and diagnosis is the key to preventing adverse cardiovascular events. With the development of imaging technology, there are numerous studies demonstrating the unique advantages of no-invasive imaging in the early screening, diagnosis, treatment, and risk assessment of coronary syndromes. However, However, recommendations for the use of noninvasive imaging modalities in previous guidelines for coronary syndromes have been incomplete. In 2022, the European Society of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, the Society of Cardiovascular Computer Imaging, and the Society of Cardiovascular Magnetic Resonance, published an expert consensus based on the latest research evidence, expert consensus and guidelines on the use of no-invasive imaging in coronary syndromes, summarizing and evaluating transthoracic echocardiography, computed tomographic angiography, cardiovascular magnetic resonance, single photon emission computed tomography, positron emission computed tomography and other noninvasive imaging modalities in the anatomical, histologic, and functional aspects, and providing a more comprehensive and detailed clinical diagnostic strategy. We aim to interpret this expert consensus and provide decision-making recommendations on the specific disease characteristics of acute coronary syndromes and chronic coronary syndromes for the reference of domestic colleagues in clinical practice and scientific researches.
[Keywords] acute coronary syndromes;chronic coronary syndromes;non-invasive imaging;expert consensus;consensus interpretation;magnetic resonance imaging

CHEN Xingrui   ZHAO Shihua*  

Department of Magnetic Resonance Imaging, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China

Corresponding author: ZHAO S H, E-mail:

Conflicts of interest   None.

ACKNOWLEDGMENTS National Key R&D Program of China (No. 2021YFF0501400, 2021YFF0501404); National Natural Science Foundation of China (No. 81930044).
Received  2023-03-03
Accepted  2023-09-14
DOI: 10.12015/issn.1674-8034.2023.10.001
Cite this article as: CHEN X R, ZHAO S H. Interpretation of expert consensus on non-invasive imaging in coronary syndromes[J]. Chin J Magn Reson Imaging, 2023, 14(10): 1-6. DOI:10.12015/issn.1674-8034.2023.10.001.

BASHORE T M, BATES E R, BERGER P B, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents[J]. J Am Coll Cardiol, 2001, 37(8): 2170-2214. DOI: 10.1016/s0735-1097(01)01346-8.
KNUUTI J, WIJNS W, SARASTE A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-477. DOI: 10.1093/eurheartj/ehz425.
COLLET J P, THIELE H, BARBATO E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Rev Esp Cardiol, 2021, 74(6): 544. DOI: 10.1016/j.rec.2021.05.002.
EDVARDSEN T, ASCH F M, DAVIDSON B, et al. Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance[J/OL]. Eur Heart J Cardiovasc Imaging, 2022, 23(2): e6-e33 [2023-03-02]. DOI: 10.1093/ehjci/jeab244.
SHAW L J, GIAMBRONE A E, BLAHA M J, et al. Long-term prognosis after coronary artery calcification testing in asymptomatic patients: a cohort study[J]. Ann Intern Med, 2015, 163(1): 14-21. DOI: 10.7326/M14-0612.
KNUUTI J, BALLO H, JUAREZ-OROZCO L E, et al. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability[J]. Eur Heart J, 2018, 39(35): 3322-3330. DOI: 10.1093/eurheartj/ehy267.
DANAD I, SZYMONIFKA J, TWISK J W R, et al. Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis[J]. Eur Heart J, 2017, 38(13): 991-998. DOI: 10.1093/eurheartj/ehw095.
PELLIKKA P A, ARRUDA-OLSON A, CHAUDHRY F A, et al. Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American society of echocardiography[J/OL]. J Am Soc Echocardiogr, 2020, 33(1) [2023-03-02]. DOI: 10.1016/j.echo.2019.07.001.
OTAKI Y, VAN KRIEKINGE S D, WEI C C, et al. Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging[J]. Eur J Nucl Med Mol Imaging, 2022, 49(6): 1881-1893. DOI: 10.1007/s00259-021-05643-2.
HAAF P, GARG P, MESSROGHLI D R, et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review[J/OL]. J Cardiovasc Magn Reson, 2016, 18(1): 89 [2023-03-02]. DOI: 10.1186/s12968-016-0308-4.
RYBICKI F J, UDELSON J E, PEACOCK W F, et al. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS appropriate utilization of cardiovascular imaging in emergency department patients with chest pain: a joint document of the American college of radiology appropriateness criteria committee and the American college of cardiology appropriate use criteria task force[J]. J Am Coll Cardiol, 2016, 67(7): 853-879. DOI: 10.1016/j.jacc.2015.09.011.
LEINER T, BOGAERT J, FRIEDRICH M G, et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance[J/OL]. J Cardiovasc Magn Reson, 2020, 22(1): 76 [2023-03-02]. DOI: 10.1186/s12968-020-00682-4.
ANTONI M L, MOLLEMA S A, DELGADO V, et al. Prognostic importance of strain and strain rate after acute myocardial infarction[J]. Eur Heart J, 2010, 31(13): 1640-1647. DOI: 10.1093/eurheartj/ehq105.
SEVERI S, PICANO E, MICHELASSI C, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography[J]. Circulation, 1994, 89(3): 1160-1173. DOI: 10.1161/01.cir.89.3.1160.
BONOW R O, MAURER G, LEE K L, et al. Myocardial viability and survival in ischemic left ventricular dysfunction[J]. N Engl J Med, 2011, 364(17): 1617-1625. DOI: 10.1056/NEJMoa1100358.
GARCIA M J, KWONG R Y, SCHERRER-CROSBIE M, et al. State of the art: imaging for myocardial viability: a scientific statement from the American heart association[J/OL]. Circ Cardiovasc Imaging, 2020, 13(7): e000053 [2023-03-02]. DOI: 10.1161/HCI.0000000000000053.
CAMICI P G, PRASAD S K, RIMOLDI O E. Stunning, hibernation, and assessment of myocardial viability[J]. Circulation, 2008, 117(1): 103-114. DOI: 10.1161/CIRCULATIONAHA.107.702993.
KIM R J, WU E, RAFAEL A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction[J]. N Engl J Med, 2000, 343(20): 1445-1453. DOI: 10.1056/NEJM200011163432003.

PREV Advances in diffusion MRI based on oscillating gradient spin echo
NEXT A study of altered resting state and dynamic functional connectivity characteristics of the hippocampus bilaterally in first-episode depression

Tel & Fax: +8610-67113815    E-mail: